Perez-Lamas L, de Paz Arias R, Diaz RMA, Montero LFC, et al. Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC study. Ann Hematol 2024 Apr 3. doi: 10.1007/s00277-024-05662.
PMID: 38568260